insights_auto
Prečo akcie DSNKY stúpli 2,20%?
Preskúmať podrobnejšiechevron_right
DSNKY:OTCMKTS
Daiichi Sankyo Co Ltd - ADR
17,18 USD
arrow_upward
+2,20%(+0,37) 1 d.
16. 10., 16:00:00 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre DSNKY…
Otvoriť
18,03 USD
Vysoká
18,03 USD
Nízka
17,13 USD
Trh. kap.
31,88 mld.
Priem. obj.
110,46 tis.
Objem
130,41 tis.
Dividenda
2,86 %
Štvrťročná dividenda
0,12 USD
Pomer cena/zárobky
20,60
Max. za 52 týž.
27,50 USD
Min. za 52 týž.
14,98 USD
Výnosy na akciu
0,83 USD
Beta
0,18
Akcie v obehu
1,86 mld.
Počet zamestnancov
20 tis.
Otvoriť
18,03 USD
Vysoká
18,03 USD
Nízka
17,13 USD
Trh. kap.
31,88 mld.
Priem. obj.
110,46 tis.
Objem
130,41 tis.
Dividenda
2,86 %
Štvrťročná dividenda
0,12 USD
Pomer cena/zárobky
20,60
Max. za 52 týž.
27,50 USD
Min. za 52 týž.
14,98 USD
Výnosy na akciu
0,83 USD
Beta
0,18
Akcie v obehu
1,86 mld.
Počet zamestnancov
20 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
The Frederick News-Post
·
pred 35 minútami
US markets are weighed down by an extended sell-off in the tech sector
TradingKey
·
pred 17 minútami
US Stock Bull Market Enters Fifth Year: Can S&P 500 Withstand Rising Treasury Yield Pressures After Doubling?
MarketWatch
·
pred 7 hodinami
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
CNN
·
pred 9 hodinami
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profil
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Informácie o subjekte Daiichi Sankyo Co Ltd - ADR
Generálny riaditeľHiroyuki Okuzawa
Zamestnanci20,2 tis.
Dátum založenia28. 9. 2005
Hlavné sídloChuo City, Tokio, Japonsko
Odvetvie-